Wire Stories
-
408Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
The 25-week weight loss study which achieved its previously reported primary endpoints also examined the effects of GS200 on insulin resistance BOSTON–(BUSINESS...
-
440Grab Reports Second Quarter 2022 Results
Q2 record Revenue of $321 million, up 79% year-over-year Q2 GMV of $5.1 billion, up 30% year-over-year Q2 Loss for the period...
-
504Genius Group Enters into a Securities Purchase Agreement for US$18.13 Million Private Placement
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group, has entered...
-
531LYNPARZA� (olaparib) Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the...
-
480
Hansen Powers Customer Care and Billing for Allente
MELBOURNE, Australia–(BUSINESS WIRE)–Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water and communications industries, is pleased...
-
431PropertyGuru Reports Second Quarter 2022 Results
Revenues Grow 44% Year Over Year in Second Quarter and 43% in First Half Total revenue of S$33.0 million in the second...
-
541
BLOCWARS Operator Blocverse DAO Announces Acquisition of Swagga Studio to Create Phygital Fashion Metaverse
NEW YORK–(BUSINESS WIRE)–Blocverse DAO, the operator of play-to-earn (P2E) project BLOCWARS, announces the acquisition of IP creator Swagga Studio to establish the...
-
444eCloudvalley Is One of The Best Companies to Work for in Asia 2022
SINGAPORE–(BUSINESS WIRE)–eCloudvalley Digital Technology was recently named one of the Best Companies to Work for in Asia by the leading human resources...
-
502Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E in Combination with KEYTRUDA� (pembrolizumab) in Cervical Cancer at European Society for Medical Oncology (ESMO) Congress 2022
SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics...
-
450
Kantar: Value of the Top 100 Most Valuable Chinese Brands Exceeds $1.24 Trillion Despite a Challenging Year
Tencent holds on to the number one spot for the second year running as Kantar BrandZ�s most valuable Chinese brand Li-Ning leads...
